99 related articles for article (PubMed ID: 603285)
21. Prognosis in cutaneous melanoma: tumor thickness as a guide to treatment.
Breslow A
Pathol Annu; 1980; 15(Pt 1):1-22. PubMed ID: 7443304
[No Abstract] [Full Text] [Related]
22. [Prognostic index in malignant melanoma. A better method to determine metastasis risk].
Schmoeckel C; Nejad KK; Braun-Falco O
Pathologe; 1980 Feb; 1(2):71-8. PubMed ID: 7208436
[No Abstract] [Full Text] [Related]
23. [After excision of primary stage I cutaneous melanoma, is an initial evaluation necessary?].
Richard-Lallemand MA
Ann Dermatol Venereol; 1995; 122(5):349-59. PubMed ID: 8572478
[No Abstract] [Full Text] [Related]
24. [Thick cutaneous melanoma: mortality factors and occurrence of metastases].
Tarwate M; Benchikhi H; Adarmouch L; Benider A; Amine M; Zamiati S; Boukind el H
Pan Afr Med J; 2014; 18():44. PubMed ID: 25368733
[TBL] [Abstract][Full Text] [Related]
25. [Metastatic malignant melanoma].
Groth W
Z Hautkr; 1989 Jul; 64(7):535-6. PubMed ID: 2773537
[No Abstract] [Full Text] [Related]
26. In-transit metastases from malignant melanoma.
Biswas B; Dabkara D; Ganguly S
Natl Med J India; 2017; 30(5):297. PubMed ID: 29916439
[No Abstract] [Full Text] [Related]
27. Microscopic satellites around a primary melanoma: another piece of the puzzle in melanoma staging.
Balch CM
Ann Surg Oncol; 2009 May; 16(5):1092-4. PubMed ID: 19247717
[No Abstract] [Full Text] [Related]
28. Malignant melanoma with zosteriform metastases.
Cuerda Galindo E; Sánchez de Paz F; Mansilla Pérez I; Poza Madalena O; Casellas Bravo M
Cutis; 2000 May; 65(5):312-4. PubMed ID: 10826094
[TBL] [Abstract][Full Text] [Related]
29. High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma.
Ekedahl H; Lauss M; Olsson H; Griewank KG; Schadendorf D; Ingvar C; Jönsson G
Pigment Cell Melanoma Res; 2016 Sep; 29(5):598-600. PubMed ID: 27301352
[No Abstract] [Full Text] [Related]
30. Regression and other factors of prognostic interest in malignant melanoma.
Sagebiel R
Arch Dermatol; 1985 Sep; 121(9):1125-6. PubMed ID: 4037836
[No Abstract] [Full Text] [Related]
31. Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
Bower M; Scoggins CR
J Ky Med Assoc; 2009 Jul; 107(7):253-8. PubMed ID: 19678500
[TBL] [Abstract][Full Text] [Related]
32. [Characterization of the end line in metastasis of human malignant melanoma].
Foa C; Aubert C; Lieutaud R; Spitalier JM
Ann Dermatol Syphiligr (Paris); 1976; 103(3):307-11. PubMed ID: 1008525
[No Abstract] [Full Text] [Related]
33. The new melanoma staging system.
Balch CM; Cascinelli N
Tumori; 2001; 87(4):S64-8. PubMed ID: 11693828
[No Abstract] [Full Text] [Related]
34. More evidence for a new melanoma paradigm.
Helm TN; Helm KF
Arch Dermatol; 2008 Jul; 144(7):946-7. PubMed ID: 18645152
[No Abstract] [Full Text] [Related]
35. Metastatic melanoma cells. Introduction.
Herlyn M
Cancer Metastasis Rev; 2005 Jun; 24(2):193-4. PubMed ID: 15986131
[No Abstract] [Full Text] [Related]
36. [Zosteriform cutaneous metastasis in melanoma].
Carlioz V; Faivre C; Balme B; Joosten H; Pradier T; Skowron F
Ann Dermatol Venereol; 2018 Feb; 145(2):113-115. PubMed ID: 29217081
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma. Prediction of metastasis and survival based on gross anatomic characteristics.
Long RT
J Med Assoc State Ala; 1979 Jul; 49(1):31-8. PubMed ID: 469435
[No Abstract] [Full Text] [Related]
38. Illuminating progression: tracking melanoma metastasis in a gene therapy setting.
Day CP; Merlino G
Pigment Cell Melanoma Res; 2011 Apr; 24(2):260-1. PubMed ID: 21226857
[No Abstract] [Full Text] [Related]
39. Fine needle aspiration biopsy of myxoid metastasis of malignant melanoma.
Rocamora A; Carrillo R; Vives R; Solera JC
Acta Cytol; 1988; 32(1):94-100. PubMed ID: 2447728
[TBL] [Abstract][Full Text] [Related]
40. Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
Nagai Y; Ishikawa O; Miyachi Y; Watanabe H
Dermatology; 1996; 192(1):8-11. PubMed ID: 8832943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
